Skip to main content
. 2024 Dec 9;11:1474426. doi: 10.3389/fcvm.2024.1474426

Table 1.

Characteristics of the study population.

Variables (%) Sleep duration (h/day)* P-value
Short (≤6 h) Average (6–8 h) Long (>8 h)
N, N (%) 4,801 (37.7) 5,034 (39.6) 2,884 (22.7)
Age (years), median (Q1-Q3) 65.0 (59.0 to 73.0) 63.0 (56.0 to 70.0) 64.0 (56.0 to 72.0) <0.001
Male, N (%) 2,073 (43.2%) 2,527 (50.2%) 1,492 (51.7%) <0.001
Rural residency, N (%) 3,150 (65.6%) 2,966 (58.9%) 1,843 (63.9%) <0.001
Education, N (%)
 Less than lower secondary education 4,409 (91.8%) 4,294 (85.3%) 2,550 (88.4%) <0.001
 Upper secondary & vocational training 351 (7.3%) 617 (12.3%) 283 (9.8%)
 Tertiary 41 (0.9%) 123 (2.4%) 51 (1.8%)
Household income per capita (¥), median (Q1-Q3) 3,000.0 (780.0 to 8,200.0) 4,280.0 (1,160.0 to 10,200.0) 3,700.0 (945.4 to 9,570.0) <0.001
BMI (Q1-Q3) 22.60 (20.41 to 25.17) 23.21 (20.98 to 25.74) 23.19 (20.97 to 25.80) <0.001
Smoking, N (%) 1,771 (36.9%) 2,014 (40.0%) 1,193 (41.4%) <0.001
Drinking, N (%) 1,813 (37.8%) 2,017 (40.1%) 1,184 (41.1%) <0.001
BADL impairments, N (%) 929 (19.5%) 467 (9.4%) 329 (11.6%) <0.001
IADL impairments, N (%) 1,147 (24%) 697 (13.9%) 466 (16.2%) <0.001
Hypertension, N (%) 1,022 (21.4%) 1,023 (20.4%) 639 (22.2%) 0.150
Diabetes/high blood sugar, N (%) 218 (4.6%) 232 (4.6%) 145 (5.1%) 0.614
Cancer, N (%) 39 (0.8%) 37 (0.7%) 21 (0.7%) 0.879
Lung disease, N (%) 467 (9.7%) 365 (7.3%) 240 (8.3%) <0.001
MRD, N (%) 61 (1.3%) 41 (0.8%) 36 (1.3%) 0.058
Psychiatric problems, N (%) 59 (1.2%) 42 (0.8%) 23 (0.8%) 0.074
Arthritis, N (%) 1,825 (38.1%) 1,364 (27.1%) 764 (26.5%) <0.001
Dyslipidemia, N (%) 339 (7.2%) 415 (8.4%) 215 (7.5%) 0.091
Liver disease, N (%) 174 (3.6%) 125 (2.5%) 74 (2.6%) <0.001
Kidney disease, N (%) 251 (5.3%) 220 (4.4%) 107 (3.7%) <0.006
Digestive disease, N (%) 1,185 (24.7%) 907 (18.0%) 500 (17.4%) <0.001
Asthma, N (%) 197 (4.1%) 162 (3.2%) 100 (3.5%) 0.057

MRD, memory-related disease.

*

Sleep duration was calculated as nighttime sleep duration plus daytime nap duration.